Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease.
about
Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Using antisense technology to ...... nd to model AATD lung disease.
@en
type
label
Using antisense technology to ...... nd to model AATD lung disease.
@en
prefLabel
Using antisense technology to ...... nd to model AATD lung disease.
@en
P2093
P2860
P356
P1476
Using antisense technology to ...... nd to model AATD lung disease.
@en
P2093
Andrew Watt
Brett P Monia
Jeffery H Teckman
Luis Alvarado
Michael L McCaleb
Sheri L Booten
Shuling Guo
Susan M Freier
P2860
P304
P356
10.4161/RDIS.28511
P577
2014-03-12T00:00:00Z